Climb Bio CLYM
NASDAQ CLYM
$11.63 +0.16 (+1.39%)
As of: Oct 1, 2026 · 12:51 PM EDT

Climb Bio (CLYM) Other Non-Current Liabilities (2021 - 2023)

Updated

Climb Bio (CLYM) recorded Other Non-Current Liabilities of $22,000 in Q4 2023, down 35.3% from the prior quarter.

Analysis

Climb Bio (CLYM) Other Non-Current Liabilities (2021 - 2023) Analysis & Trends

Starting with Q4 2021, Climb Bio's Other Non-Current Liabilities history includes 5 quarters.

  • Across earlier years, Other Non-Current Liabilities came in at $7,000 in FY2021.
  • The Q4 2023 figure is the lowest quarterly Other Non-Current Liabilities since Q4 2021.
  • Per Business Quant, the preceding three quarters came in at $34,000 (Q3 2023), $55,000 (Q2 2023) and $87,000 (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Climb Bio 873.49 Mn 873.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 22,000.00
Sep 30, 2023 34,000.00
Jun 30, 2023 55,000.00
Mar 31, 2023 87,000.00
Dec 31, 2021 7,000.00
API Access

Climb Bio Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=CLYM&period=max&api_key=YOUR_API_KEY